Innovation Days
About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2022
2021
2020
2019
2018
2017
04
Jun
2018
16:30 E.S.T.
FDA Grants Cellectis IND Approval for UCART22 in B-ALL
Read more
22
May
2018
19:15 E.S.T.
Approval of UCART123 Amendment in AML to Accelerate Clinical Development
Read more
22
May
2018
16:00 E.S.T.
Calyxt Announces Successful Closing of $60.9 Million Public Offering
Read more
21
May
2018
08:30 E.S.T.
Calyxt Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read more
18
May
2018
08:55 E.S.T.
Calyxt Announces Upsizing and Pricing of Follow-On Offering
Read more
15
May
2018
17:45 E.S.T.
Calyxt Announces Launch of Proposed Follow-On Offering
Read more
10
May
2018
17:15 E.S.T.
Cellectis to Present Data at the 2018 ASGCT Annual Meeting
Read more
07
May
2018
16:30 E.S.T.
Cellectis Reports 1st Quarter 2018 Financial Results
Read more
02
May
2018
16:30 E.S.T.
Cellectis Files IND for UCART22 in Acute Lymphoblastic Leukemia (B-ALL)
Read more
01
May
2018
07:00 E.S.T.
Harvard’s Wyss Institute partners with Cellectis to recode the human genome
Read more
Prev
1
2
3
4
Next